Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

DNA Ginkgo Bioworks Holdings, Inc.

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Most retrieval-augmented models work by breaking down documents into small chunks and retrieving only the most relevant ones. However, this approach has some limitations: Loss of Context: Retrieving ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

A simple voice AI assistant, ready for extension and customization A voice AI pipeline with models from OpenAI, Cartesia, and AssemblyAI served through LiveKit Cloud This project is designed to work ...

Steve Nix is a member of the Society of American Foresters and a former forest resources analyst for the state of Alabama. According to National Wildlife Federation, there are two varieties of Douglas ...

就在昨天，新加坡国立大学、中国人民大学、复旦大学等多所顶尖机构联合发布了一篇AI Agent 记忆（Memory）综述。 当前的 LLM 应用开发正面临严重的“记忆碎片化”问题：我们有用于短期记忆的 KV Cache，有用于知识检索的 RAG，还有用于长期交互的 MemGPT 类架构，但缺乏统一的理论指导。这篇综述不仅是对现有工作的盘点，更是一份解决“灾难性遗忘”与“上下文溢出”的系统方案。它详细 ...

Getting good at LeetCode Java isn’t just about solving problems; it’s about having a good plan. You need to know where to ...